Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Kopetz SE"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Yaeger R; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Uboha NV; Division of Hematology and Oncology, Department of Medicine, University of Wisconsin, Madison, Wisconsin., Pelster MS; Sarah Cannon Research Institute, Tennessee Oncology, Nashville, Tennessee., Bekaii-Saab TS; Department of Medical Oncology and Hematology, Mayo Clinic, Scottsdale, Arizona., Barve M; Mary Crowley Cancer Research Center, Dallas, Texas., Saltzman J; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, Ohio., Sabari JK; Division of Medical Oncology, Perlmutter Cancer Center, New York University Langone Health, New York, New York., Peguero JA; Department of Research, Oncology Consultants PA, Houston, Texas., Paulson AS; Department of Medical Oncology, Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas, Texas., Jänne PA; Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Cruz-Correa M; PanOncology Trials, San Juan, Puerto Rico., Anderes K; Mirati Therapeutics, a wholly owned subsidiary of Bristol Myers Squibb Company, San Diego, California., Velastegui K; Mirati Therapeutics, a wholly owned subsidiary of Bristol Myers Squibb Company, San Diego, California., Yan X; Mirati Therapeutics, a wholly owned subsidiary of Bristol Myers Squibb Company, San Diego, California., Der-Torossian H; Mirati Therapeutics, a wholly owned subsidiary of Bristol Myers Squibb Company, San Diego, California., Klempner SJ; Division of Hematology-Oncology, Massachusetts General Cancer Center, Boston, Massachusetts., Kopetz SE; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
Cancer discovery [Cancer Discov] 2024 Jun 03; Vol. 14 (6), pp. 982-993.
Autor:
Pilié PG; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Giuliani V; TRACTION (Translational Research to Advance Therapeutics and Innovation in Oncology), The University of Texas MD Anderson Cancer Center, Houston, Texas., Wang WL; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., McGrail DJ; Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, Ohio., Bristow CA; TRACTION (Translational Research to Advance Therapeutics and Innovation in Oncology), The University of Texas MD Anderson Cancer Center, Houston, Texas., Ngoi NYL; Department of Investigational Cancer Therapeutics (Phase I Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kyewalabye K; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wani KM; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Le H; Department of Investigational Cancer Therapeutics (Phase I Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Campbell E; Department of Investigational Cancer Therapeutics (Phase I Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Sanchez NS; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Yang D; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Gheeya JS; The University of Texas Health Science Center at Houston, Houston, Texas., Goswamy RV; The University of Texas Health Science Center at Houston, Houston, Texas., Holla V; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Shaw KR; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Meric-Bernstam F; Department of Investigational Cancer Therapeutics (Phase I Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Liu CY; TRACTION (Translational Research to Advance Therapeutics and Innovation in Oncology), The University of Texas MD Anderson Cancer Center, Houston, Texas., Ma X; TRACTION (Translational Research to Advance Therapeutics and Innovation in Oncology), The University of Texas MD Anderson Cancer Center, Houston, Texas., Feng N; TRACTION (Translational Research to Advance Therapeutics and Innovation in Oncology), The University of Texas MD Anderson Cancer Center, Houston, Texas., Machado AA; TRACTION (Translational Research to Advance Therapeutics and Innovation in Oncology), The University of Texas MD Anderson Cancer Center, Houston, Texas., Bardenhagen JP; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas., Vellano CP; TRACTION (Translational Research to Advance Therapeutics and Innovation in Oncology), The University of Texas MD Anderson Cancer Center, Houston, Texas., Marszalek JR; TRACTION (Translational Research to Advance Therapeutics and Innovation in Oncology), The University of Texas MD Anderson Cancer Center, Houston, Texas., Rajendra E; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Piscitello D; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Johnson TI; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Likhatcheva M; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Elinati E; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Majithiya J; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Neves J; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Grinkevich V; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Ranzani M; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Luzarraga MR; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Boursier M; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Armstrong L; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Geo L; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Lillo G; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Tse WY; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Lazar AJ; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kopetz SE; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Geck Do MK; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lively S; ChemPartner Corporation, San Francisco, California., Johnson MG; ChemPartner Corporation, San Francisco, California., Robinson HMR; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Smith GCM; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Carroll CL; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas., Di Francesco ME; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas., Jones P; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas., Heffernan TP; TRACTION (Translational Research to Advance Therapeutics and Innovation in Oncology), The University of Texas MD Anderson Cancer Center, Houston, Texas., Yap TA; Department of Investigational Cancer Therapeutics (Phase I Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 May 15; Vol. 30 (10), pp. 2121-2139.
Autor:
Bose S; Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC 27708, USA., Barroso M; Department of Molecular and Cellular Physiology, Albany Medical College, Albany, NY 12208, USA., Chheda MG; Department of Medicine, Washington University in St. Louis, St. Louis, MO, 63110 USA., Clevers H; Oncode Institute, Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center, Uppsalalaan 8, Utrecht, 3584 CT, Netherlands; Research and Early Development (pRED) of F. Hoffmann-La Roche Ltd, Roche Pharma, Basel, Switzerland., Elez E; Vall d'Hebron Hospital Campus and Institute of Oncology, International Oncology Bureau-Quiron, University of Vic-Central University of Catalonia, Barcelona, 08035 Spain., Kaochar S; Department of Medicine, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Kopetz SE; The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Li XN; Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL 60611, USA., Meric-Bernstam F; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Meyer CA; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA 02215, USA; Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC 27708, USA., Mou H; The Wistar Institute, Philadelphia, PA 19104, USA., Naegle KM; Department of Biomedical Engineering and the Center for Public Health Genomics, University of Virginia, Charlottesville, VA 22903, USA., Pera MF; The Jackson Laboratory, Bar Harbor, ME 04660, USA., Perova Z; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SD, UK., Politi KA; Departments of Pathology and Internal Medicine (Medical Oncology), Yale School of Medicine and Yale Cancer Center, New Haven, CT 06510, USA., Raphael BJ; Department of Computer Science, Princeton University, Princeton, NJ 08540, USA., Robson P; The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA; Department of Genetics and Genome Sciences, University of Connecticut School of Medicine, Farmington, CT 06032, USA; Institute for Systems Genomics, University of Connecticut, Farmington, CT 06032, USA., Sears RC; Department of Medical and Molecular Genetics, Oregon Health & Science University, Portland, OR 97201, USA., Tabernero J; Vall d'Hebron Hospital Campus and Institute of Oncology, International Oncology Bureau-Quiron, University of Vic-Central University of Catalonia, Barcelona, 08035 Spain., Tuveson DA; Lustgarten Foundation Pancreatic Cancer Research Laboratory at Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA., Welm AL; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA., Welm BE; Department of Surgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA., Willey CD; Department of Radiation Oncology, The University of Alabama at Birmingham, Birmingham, AL 35294, USA., Salnikow K; Division of Cancer Biology, National Cancer Institute, NIH, Rockville, MD 20850, USA. Electronic address: salnikok@mail.nih.gov., Chuang JH; The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA; Department of Genetics and Genome Sciences, University of Connecticut School of Medicine, Farmington, CT 06032, USA; Institute for Systems Genomics, University of Connecticut, Farmington, CT 06032, USA. Electronic address: jeff.chuang@jax.org., Shen X; Terasaki Institute for Biomedical Innovation, Los Angeles, CA 90024, USA. Electronic address: xiling.shen@terasaki.org.
Publikováno v:
Cancer cell [Cancer Cell] 2022 Dec 12; Vol. 40 (12), pp. 1448-1453. Date of Electronic Publication: 2022 Oct 20.
Colorectal Liver Micrometastases: Association with RAS/TP53 Co-Mutation and Prognosis after Surgery.
Autor:
Chun YS; From the Departments of Surgical Oncology (Chun, Nishioka, Arvide, Vauthey), University of Texas MD Anderson Cancer Center, Houston, TX., Passot G; the Departments of Digestive Surgery (Passot), Lyon Sud University Hospital, Hospices Civils de Lyon, Lyon, France., Nishioka Y; From the Departments of Surgical Oncology (Chun, Nishioka, Arvide, Vauthey), University of Texas MD Anderson Cancer Center, Houston, TX., Katkhuda R; Pathology (Katkhuda, Maru), University of Texas MD Anderson Cancer Center, Houston, TX., Arvide EM; From the Departments of Surgical Oncology (Chun, Nishioka, Arvide, Vauthey), University of Texas MD Anderson Cancer Center, Houston, TX., Benzerdjeb N; Pathology (Benzerdjeb), Lyon Sud University Hospital, Hospices Civils de Lyon, Lyon, France., Lopez J; Biochemistry and Molecular Biology (Lopez), Lyon Sud University Hospital, Hospices Civils de Lyon, Lyon, France., Kopetz SE; Gastrointestinal Medical Oncology (Kopetz), University of Texas MD Anderson Cancer Center, Houston, TX., Maru DM; Pathology (Katkhuda, Maru), University of Texas MD Anderson Cancer Center, Houston, TX., Vauthey JN; From the Departments of Surgical Oncology (Chun, Nishioka, Arvide, Vauthey), University of Texas MD Anderson Cancer Center, Houston, TX.
Publikováno v:
Journal of the American College of Surgeons [J Am Coll Surg] 2022 Jul 01; Vol. 235 (1), pp. 8-16. Date of Electronic Publication: 2022 Apr 08.
Autor:
Orouji E; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Raman AT; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachussetts, USA.; Graduate Program in Quantitative and Computational Biosciences, Baylor College of Medicine, Houston, Texas, USA., Singh AK; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Sorokin A; Department of GI Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Arslan E; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ghosh AK; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Schulz J; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Terranova C; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Jiang S; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Tang M; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Maitituoheti M; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Callahan SC; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Barrodia P; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Tomczak K; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Jiang Y; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Jiang Z; Department of GI Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Davis JS; Department of GI Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ghosh S; Center for Translational Cancer Research, University of Texas Health Science Center at Houston, Houston, Texas, USA., Lee HM; Department of GI Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Reyes-Uribe L; Department of Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Chang K; Department of Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Liu Y; University of Chicago Medical Center, Chicago, Illinois, USA., Chen H; Department of GI Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Azhdarinia A; Center for Translational Cancer Research, University of Texas Health Science Center at Houston, Houston, Texas, USA., Morris J; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Vilar E; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Carmon KS; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Center for Translational Cancer Research, University of Texas Health Science Center at Houston, Houston, Texas, USA., Kopetz SE; Department of GI Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Rai K; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA krai@mdanderson.org.; Graduate Program in Quantitative and Computational Biosciences, Baylor College of Medicine, Houston, Texas, USA.; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
Gut [Gut] 2022 May; Vol. 71 (5), pp. 938-949. Date of Electronic Publication: 2021 May 31.
Autor:
Khan S; Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, FL, 32610, USA. khansajid@cop.ufl.edu., Wiegand J; Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, FL, 32610, USA., Zhang P; Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, FL, USA., Hu W; Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, FL, USA., Thummuri D; Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, FL, 32610, USA., Budamagunta V; Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, FL, 32610, USA.; Department of Neuroscience, College of Medicine, University of Florida, Gainesville, FL, USA.; Genetics and Genomics Graduate Program, Genetics Institute, College of Medicine, University of Florida, Gainesville, FL, USA., Hua N; Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, FL, 32610, USA., Jin L; Department of Anatomy and Cell Biology, College of Medicine, University of Florida, Gainesville, FL, USA., Allegra CJ; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA., Kopetz SE; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zajac-Kaye M; Department of Anatomy and Cell Biology, College of Medicine, University of Florida, Gainesville, FL, USA., Kaye FJ; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA., Zheng G; Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, FL, USA., Zhou D; Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, FL, 32610, USA. zhoudaohong@cop.ufl.edu.
Publikováno v:
Journal of hematology & oncology [J Hematol Oncol] 2022 Mar 09; Vol. 15 (1), pp. 23. Date of Electronic Publication: 2022 Mar 09.
Autor:
Mason MC; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Tzeng CD; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Tran Cao HS; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Aloia TA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Newhook TE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Overman MJ; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Kopetz SE; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Vauthey JN; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Chun YS; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: yschun@mdanderson.org.
Publikováno v:
Journal of the American College of Surgeons [J Am Coll Surg] 2021 Jul; Vol. 233 (1), pp. 82-89.e1. Date of Electronic Publication: 2021 Mar 02.
Autor:
Yamashita S; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Chun YS; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Kopetz SE; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Maru D; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Conrad C; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Aloia TA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Vauthey JN; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Publikováno v:
Annals of surgery [Ann Surg] 2020 Dec; Vol. 272 (6), pp. 1080-1085.
Autor:
Chun YS; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Passot G; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Yamashita S; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Nusrat M; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Katsonis P; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX., Loree JM; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Conrad C; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Tzeng CD; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Xiao L; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX., Aloia TA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Eng C; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Kopetz SE; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Lichtarge O; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX., Vauthey JN; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Publikováno v:
Annals of surgery [Ann Surg] 2019 May; Vol. 269 (5), pp. 917-923.